Patents by Inventor Aifeng ZOU

Aifeng ZOU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CALCIUM-SENSING RECEPTOR AGONIST COMPOSITION AND APPLICATION THEREOF
    Publication number: 20240269227
    Abstract: Provided are a calcium-sensing receptor (CaSR) agonist composition and an application thereof. Specifically, provided is a pharmaceutical composition of a polypeptide CaSR agonist, the composition comprising an active ingredient, a buffer and an osmotic pressure regulator. The present composition has high stability, may be stored for a long time, may effectively reduce the plasma parathyroid hormone, and has a low level of histamine release.
    Type: Application
    Filed: June 8, 2022
    Publication date: August 15, 2024
    Inventors: Xinyong Tong, Aifeng Zou, Haifeng Wang, Tingting Yang, Yi Yang, Yin Zhou
  • LIPOSOME CONTAINING ETHYLENEDIAMINE TETRAACETIC ACID OR SALT THEREOF AND ERIBULIN OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
    Publication number: 20230201119
    Abstract: Provided are a liposome containing Eribulin or a pharmaceutically acceptable salt thereof and a preparation method therefor. An inner aqueous phase of the liposome contains Eribulin or a salt thereof, and one or more selected from ethylenediamine tetraacetic acid, phosphoric acid, pentetic acid, or salts thereof. Further provided are a pharmaceutical composition containing the aforementioned liposome and a preparation method therefor.
    Type: Application
    Filed: May 28, 2021
    Publication date: June 29, 2023
    Inventors: Xinyong TONG, Aifeng ZOU, Qibo ZHANG, Dan LIU, Zhonghua MA, Yanping WANG
  • SUSTAINED-RELEASE LIPID COMPOSITION AND PREPARATION METHOD THEREFOR
    Publication number: 20220249375
    Abstract: Disclosed are a sustained-release lipid composition and a preparation method therefore. Specifically, the present invention relates to a solid composition containing lipids and a liposome composition obtained therefrom, wherein the liposomes have improved release properties.
    Type: Application
    Filed: June 28, 2020
    Publication date: August 11, 2022
    Applicants: JIANGSU HENGRUI MEDICINE CO., LTD., SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.
    Inventors: Xinyong TONG, Aifeng ZOU, Ziqing DUAN, Pingping WANG, Dong LI, Wei HE
  • PHARMACEUTICAL COMPOSITION OF KOR RECEPTOR AGONIST
    Publication number: 20210205404
    Abstract: Disclosed in the present invention is a pharmaceutical composition of a KOR receptor agonist, which comprises 4-amino-N—[N2-[N—[N—[N-((R)-2-phenyl propyl)glycyl]-D-phenylalanyl]-D-leucyl]-D-lysyl]piperidine-4-carboxylic acid or available salts thereof, and an acetate buffer solution.
    Type: Application
    Filed: May 15, 2019
    Publication date: July 8, 2021
    Inventors: Xinyong TONG, Aifeng ZOU, Yin ZHOU, Yi FAN, Weikang TAO